Nature Medicine, Published online: 27 May 2026; doi:10.1038/s41591-026-04418-2
What Utah’s clinical AI sandbox reveals about independent oversight
Marmoset models for the study of autism spectrum disorders
Neurological and psychiatric disorders are a highly prevalent source of global disability. For the majority of these conditions, including autism spectrum disorder (ASD), disease-modifying treatments remain unavailable, and existing pharmacological interventions are largely palliative.
The multiple scales of astrocytic functional units
Nature Neuroscience, Published online: 27 May 2026; doi:10.1038/s41593-026-02308-x
Astrocytes modulate complex brain functions. These ubiquitous glial cells constitute a multilayered system of functional units that operate across multiple spatial scales, thereby increasing the degrees of freedom in brain information processing.
NIA and Alzheimer’s Society partner to bolster dementia innovation
The NHS Innovation Accelerator and Alzheimer’s Society have launched a partnership to support promising dementia innovations.
The Download: keeping up with AI, and the future of IVF
This is today’s edition of The Download, our weekday newsletter that provides a daily dose of what’s going on in the world of technology.
Stay on top of what’s going on in AI this summer
Here at MIT Technology Review, we understand exactly how relentless the pace of news from the world of artificial intelligence feels. New models and capabilities crop up as fast as we can cover them, and the ripple effects they send through tech and wider society are never far behind.
Our unique strength lies in cutting through the day-to-day noise to help you understand what’s really happening, and what lies around the corner.
That’s why we created our list of 10 Things That Matter in AI Right Now, unveiled at our flagship AI event EmTech AI a few weeks back (check the list out if you haven’t already!) And it’s why we publish so many stories dedicated to explaining how AI works, and what’s coming next. We also regularly run live subscriber-only Roundtables events—you can still catch up on last week’s session, where we explored how AI might enter the physical realm via world models.
Right now, there’s a 25% discount on subscriptions. Sign up now to deepen your understanding of AI this summer. You can also join the conversation by subscribing to The Algorithm, our free weekly newsletter all about the latest in AI.
MIT Technology Review Narrated: what’s next for IVF
IVF has brought millions of babies into the world over the last four decades. But the process can still be slow, painful, and expensive—and far from guaranteed to work. Now, a wave of new technologies aims to change that.
Researchers are using AI to identify promising sperm and embryos, developing robotic systems that could automate parts of the IVF process, and even exploring controversial genetic editing techniques designed to prevent inherited disease.
The technologies could make IVF more effective and accessible. But they’re also raising difficult ethical questions about how far reproductive medicine should go.
—Jessica Hamzelou
This is our latest story to be turned into an MIT Technology Review Narrated podcast, which we publish each week on Spotify and Apple Podcasts. Just navigate to MIT Technology Review Narrated on either platform, and follow us to get all our new content as it’s released.
The must-reads
I’ve combed the internet to find you today’s most fun/important/scary/fascinating stories about technology.
1 NASA unveiled plans for three uncrewed missions to the Moon this year
They’re part of preparations for a crewed landing in 2028. (The Verge)
+ And steps to build the first lunar base at the Moon’s south pole. (NBC News)
+ Jeff Bezos’s Blue Origin will lead the first uncrewed mission. (WP $)
+ NASA is building the first nuclear reactor-powered spacecraft. (MIT Technology Review)
2 Samsung’s largest unions have approved a landmark bonus scheme
The deal averts a massive strike at the world’s largest memory-chip maker. (WSJ $)
+ Chip workers will get an average bonus of about $340,000. (Bloomberg $)
+ The dispute centered on who profits from the AI boom. (BI)
+ Resistance to AI is growing. (MIT Technology Review)
3 Elon Musk accused the Pentagon of misusing Starlink for drones
He says military use of the system violates SpaceX rules. (Ars Technica)
+ The DoD is disputing a Starlink price hike during the Iran war. (Reuters $)
+ Stratospheric internet could take off this year. (MIT Technology Review)
4 China has overhauled the world’s biggest surveillance network with AI
Beijing is pushing law enforcement towards predictive policing. (FT $)
+ Police use of smart glasses is also booming in China. (Gizmodo)
+ LLMs could supercharge mass surveillance. (MIT Technology Review)
5 Space Force is awarding SpaceX $2 billion for a military data network
It will connect military sensors and weapons platforms worldwide. (Reuters $)
+ The contract comes amid concerns about SpaceX’s AI business. (WSJ $)
+ Speculation is growing around a possible SpaceX-Tesla merger. (CNBC)
6 Taiwan suspects Nvidia chips were smuggled to China via Japan
To circumvent US restrictions. (Bloomberg $)
+ Is China about to win the AI race? (MIT Technology Review)
7 Booming AI chip demand has created two new $1 trillion companies
South Korea’s SK Hynix and the US’ Micron have hit the landmark. (BBC)
8 AI has sparked a surge in demand for cybersecurity experts
Thanks to a glut of new code and alarm over powerful models. (NYT $)
+ AI is making online swindles easier. (MIT Technology Review)
9 Internet is coming back in Iran after a three-month blackout
Although it isn’t clear if the reconnection is permanent. (Wired $)
10 Physicists are rethinking the role of gravity in quantum mechanics
There’s a new theory for how our everyday world emerges. (New Scientist $)
Quote of the day
“AI and its capabilities represent something analogous to the Second Coming.”
—Jeremy Nixon, the cofounder of AGI House and a former Google Brain researcher, tells the New York Times how Silicon Valley’s innovations could affect the pope.
One More Thing
ANDREW MERRITT
Inside the experimental world of animal infrastructure
In the mid-2000s, toads were meeting a gruesome end near Ede, a leafy old town in the Netherlands. Residents responded by building wildlife tunnels beneath the road to help them reach their breeding ponds safely.
The crossings became popular. But a few years later, researchers found the local toad population had crashed from more than 10,000 to fewer than 1,000.
The case reflects a wider global push to build wildlife crossings and other forms of “animal infrastructure.” But do they actually help animal populations recover? Read the full story to find out.
—Matthew Ponsford
We can still have nice things
A place for comfort, fun, and distraction to brighten up your day. (Got any ideas? Drop me a line.)
+ The votes for “International Mollusc of the Year” are finally in.
+ Track aircraft in real time across a gorgeous 3D digital globe using live flight data.
+ NASA’s Psyche spacecraft has delivered breathtaking new close-up images of Mars.
+ This deep dive into instant coffee reveals the extraordinary engineering effort behind making it vaguely drinkable.
Penny Kechagioglou: ‘We’ve become too attached to AI’
Ahead of Digital Health Summer Schools, Dr Penny Kechagioglou discusses clinical leadership and health inequalities.
WuXi’s Facility in China Receives Brazilian GMP Certification for Dengue Vaccine Manufacturing
CDMO WuXi Vaccines, a wholly-owned subsidiary of WuXi Biologics, reports that its drug substance facility (MFG23) located in Suzhou, China, has received GMP certification from Brazil’s Agência Nacional de Vigilância Sanitária (ANVISA). The facility provides integrated manufacturing services for Instituto Butantan’s dengue vaccine (Butantan-DV) production project.
“The GMP certification of our DS facility, our second certification from ANVISA, represents a pivotal step in advancing our dengue vaccine project with Instituto Butantan and establishing a solid foundation to deliver on our shared commitment to expand access to high-quality dengue vaccines,” said Jian Dong, CEO of WuXi Vaccines. “Adhered to premier quality standards and powered by our integrated solutions and technologies, we remain committed to driving greater access to safe, effective, and affordable vaccines worldwide.”
Based on the commercial manufacturing agreement with Instituto Butantan and Fundação Butantan, WuXi Vaccines will provide end-to-end services, including drug substance and drug product manufacturing and quality control for the 5-dose dengue vaccine, according to Dong. The partnership plans to rapidly scale up vaccine capacity, aiming to deliver millions of doses to shield Brazil’s population from dengue. In November 2025, the single-dose Butantan-DV received ANVISA approval for use with individuals aged 12 to 59.
The post WuXi’s Facility in China Receives Brazilian GMP Certification for Dengue Vaccine Manufacturing appeared first on GEN – Genetic Engineering and Biotechnology News.
Trump says latest medical exam went ‘PERFECTLY’
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here.
Good morning. You know that one Emily Dickinson poem? “Because I could not stop for Death – / He kindly stopped for me – / The Carriage held but just Ourselves – / And Immortality.” I’d love to hear a longevity enthusiast’s close reading. In the meantime, scroll down for a great story from Sarah Todd on the movement’s latest death-defying initiatives.
STAT+: How Stanford patients help expose ‘fault lines’ in health AI adoption
At Stanford University, it’s easy to get carried away with technology. The computer mouse was invented there. So was Google. And now, it’s pumping out a myriad of tools for artificial intelligence in health care.
But for the last year and a half, Stanford’s hospital has been asking patients about new AI tools before they roll them out.
Eric Gries is one of those people, handpicked by Stanford as part of a “patient panel.” Gries was the caregiver for his wife while she was first on a left ventricular assist device (LVAD), then had a heart transplant. He later became the temporary caregiver for his brother-in-law when he also had a heart transplant.
Opinion: The patients demanding unvaccinated blood transfusions
If you’ve ever donated blood, you know about the screening process: Have you traveled to certain countries? Engaged in risky sexual activities?
One question that they don’t ask is: Have you been vaccinated against Covid-19?